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MtaN (Multidrug Transporter Activation, N terminus)
is a constitutive, transcriptionally active 109-residue
truncation mutant, which contains only the N-terminal
DNA-binding and dimerization domains of MerR family
member Mta. The 2.75 Å resolution crystal structure of
apo-MtaN reveals a winged helix-turn-helix protein with
a protruding 8-turn helix (5) that is involved in dimer-
ization by the formation of an antiparallel coiled-coil.
The hydrophobic core and helices 1 through 4 are
structurally homologous to MerR family member BmrR
bound to DNA, whereas one wing (Wing 1) is shifted.
Differences between the orientation of 5 with respect
to the core and the revolution of the antiparallel coiled-
coil lead to significantly altered conformations of MtaN
and BmrR dimers. These shifts result in a conformation
of MtaN that appears to be incompatible with the tran-
scription activation mechanism of BmrR and suggest
that additional DNA-induced structural changes are
necessary.
Bacterial multidrug resistance (MDR)1 is a growing threat to
human health. One key component of MDR is the efflux of
structurally and chemically diverse compounds, including an-
tibiotics, antiseptics, and disinfectants, by membrane-bound
multidrug transporters (1, 2). Although often regulated by glo-
bal regulators (3, 4) such as MarA (5), which activates over a
dozen genes (6, 7), many MDR genes are regulated specifically,
such as qacA by QacR (8) and emrAB by EmrR (9). In Bacillus
subtilis, BmrR (10) and BltR (11), members of the MerR family
(12), regulate transcription of the MDR transporter genes bmr
and blt, respectively. MtaN (multidrug transporter activation,
N terminus), another MerR family member, is a global activa-
tor of B. subtilis multidrug transporter genes and constitu-
tively activates transcription of bmr and blt, another putative
membrane protein gene (ydfK) and its own gene (13).
MerR proteins range from relatively small size, such as the
Escherichia coli MerR (144 residues per monomer) and E. coli
ZntR (141 residues), to those over a hundred amino acid resi-
dues longer including B. subtilis BmrR (278 residues) or Strep-
tomyces lividans TipAL (253 residues). These proteins form
homodimers that regulate genes to combat a variety of cellular
stresses. ZntR (14), CueR (15), PMTR (16), and MerR (12) bind
divalent metal ions to activate their respective metal resistance
systems, whereas SoxR responds to oxidative stress through
redox disassembly of its iron-sulfur centers (17). NolA is in-
volved in the nodulation process in Bradyrhizobium japonicum
by responding to nodulation factors from soybeans (18). BmrR
binds toxic lipophilic cations, although physiologically relevant
ligand(s) of BmrR have yet to be identified (10). TipAL co-
valently binds the large antibiotic thiostrepton (19). Whereas
MtaN is able to activate transcription of multidrug transport-
ers and full-length Mta is closely related (40% sequence iden-
tity) to TipAL, Mta is not induced by thiostrepton (13), and the
ligand or ligands of Mta remain unknown.
The N-terminal domain of each MerR subunit, the most
conserved segment, contains a winged helix-turn-helix motif
(20) and the dimerization region, which comprises half of an
antiparallel coiled-coil (21). This 110-residue domain is the
signature of the MerR family, and it is likely to be structurally
and functionally conserved. Beyond the winged helix-turn-he-
lix motif, there appears to be no significant sequence or struc-
tural homology between MerR family members and other
known gene regulators. The variable length C-terminal domain
of MerR proteins contains ligand or coactivator binding ele-
ments that have been tailored to recognize their widely diver-
gent and non-overlapping signals. Not surprisingly, the larger
proteins bind larger coactivators, whereas the smaller proteins
appear to be the minimum size necessary to respond to a
divalent cation.
The function of the C terminus is to modulate the transcrip-
tional activation of MerR family members by keeping the pro-
tein/DNA complex in a transcriptionally inactive form until a
coactivator is bound, at which time repression is relieved, and
the protein is able to up-regulate transcription (13, 22). MtaN
is an unusual MerR family member because the protein lacks
this modulation domain, which leads to its constitutive activa-
tion of cognate promoters (13). Because MtaN constitutively
activates its own transcription, cells containing mtaN produce
high levels of this protein through positive feedback. Eventu-
ally, elevated levels of MtaN overcome its lower affinities for
the bmr and blt promoters, and those genes are activated (13).
MtaN appears to represent the smallest active form of the
MerR family of transcriptional regulators.
An unusual feature of the genes that are regulated by MerR
family members is the 19-base pair (bp) separation of the 10
and 35 promoter elements (23), which is 17 bp in most bac-
terial promoters (24, 25). The 19-bp spacer appears to prevent
open complex formation by RNA polymerase in the absence of
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an activator (23). This unusual promoter structure has led to a
model of transcription regulation by these proteins in which
activation is achieved by DNA distortion and untwisting (12,
26). The recent crystal structure of BmrR bound to DNA and
coactivator has delineated a significant portion of the activa-
tion mechanism (27). The ternary complex shows that the
center of the DNA-binding site is bent, untwisted, and
bunched-up, shortening the effective length of the DNA and
reconfiguring the RNA polymerase binding sites to resemble
more closely a 17-bp spacer and allow open complex formation.
The BmrR-drug-DNA complex provides insight into one facet
of transcription regulation by the MerR family. However, the
extent of the conformational changes of these proteins needed
to effect DNA binding and transcription activation, if any, are
unknown. To address this aspect of the mechanism of MerR
family transcription activation, we solved the crystal structure
of MtaN to 2.75 Å resolution. Comparison of the structures of
MtaN and DNA/drug-bound BmrR reveals their overall struc-
tural similarity, as well as significant tertiary and quaternary
differences.
MATERIALS AND METHODS
Data Collection and Phase Determination—MtaN was expressed,
purified, and crystallized as previously reported (22). Both multiwave-
length anomalous diffraction (MAD) and native x-ray intensity data
were collected on cryocooled crystals at 170 °C at the Stanford Syn-
chrotron Radiation Laboratory (SSRL) on beamlines 1-5 and 7-1, re-
spectively (22). Native intensity data were collected at   1.08 Å. MAD
data were collected from a selenomethionine-containing protein crystal
at four wavelengths (Table I). Data were processed using MOSFLM
(28). The structure of MtaN was determined by MAD phasing (29) as a
special case of multiple isomorphous replacement (30). Three of five
possible selenomethionine sites were located using SOLVE (31), and
these revealed the space group to be I212121. A fourth selenium site was
located through difference Fourier analysis (22). The fifth possible site,
the N-terminal methionine, was not found and likely cleaved during
normal protein processing by E. coli. The four sites were refined and
electron density maps calculated after density modification, including
solvent flipping (63% estimated solvent) and histogram matching as
implemented in CNS (32). The figure of merit for these phases in-
creased from 0.69 in the initial MAD derived phases to 0.98 after
density modification (resolution limit 58.0–2.9 Å). Initial electron den-
sity maps, calculated to 3.0 Å resolution, revealed a mostly -helical
structure, sections of well connected backbone, and the locations of
many side chains. The selenomethionine sites were later used to deter-
mine unambiguously the register of the protein chain.
Model Building and Refinement—An initial polyalanine trace was
built manually to these maps with O (33). Iterative cycles of model
building, including some side chains, with O and refinement with CNS
continued until the usefulness of the MAD data was exhausted, at
which point the MAD-derived model was used to solve the higher
resolution native intensity data set by molecular replacement using
EPMR (34). Refinement and model rebuilding were done alternately to
fit the complete model using sigma A-weighted 2Fo-Fc and Fo-Fc maps
(Fig. 6). Prior to refinement, 5% of the native data was set aside for
cross-validation and Rfree was used as a measure of the validity and
progress of the model. Residues 2–107 are included in the final model
but the final 2 residues of the protein, a 2-residue linker and the
hexa-His tag are disordered and not included. The final Rfactor and Rfree
are 0.227 and 0.287, respectively for data from 25.0–2.75 Å resolution.
Four amino acids (residues Glu-67, His-71, Asn-73, and Lys-90) were
refined as alanines because their side chain densities are missing or
poor. The final model contains 16 solvent molecules. The stereochem-
istry of this structure was assessed with PROCHECK (35), which cal-
culated 89% of all residues in the most favored region of the Ramachan-
dran plot and none in the generously allowed or disallowed regions.
Figs. 1, 2, 5, and 6 were produced with Swiss PDB viewer (50) and
POV-ray (www.povray.org).
Alignment—An alignment of the amino acid sequences of ten mem-
bers of the MerR family was performed using ClustalW (36) and aided
by the structures of MtaN and BmrR. This alignment was examined
using the computer programs Alscript (37) and AMAS (38). Functional
conservation across the family was determined using a threshold value
of 0.4 as described in the documentation of AMAS. Residues from the N
terminus through residue 69 of MtaN were aligned simply and consis-
tently, however when different parameters were entered into the Clust-
alW program, alignments C-terminal to residue 69 varied slightly and
those presented in Fig. 3 represent its best fit. The alignment of BmrR
to MtaN was confirmed by visual inspection of their structures. The
coordinates and structure factor amplitudes have been deposited in the
RCSB Protein Data Bank (accession code 1JBG).
RESULTS AND DISCUSSION
Overall Structure—The asymmetric unit contains a mono-
mer of MtaN (Fig. 1). The electron density is clear for 106
residues; the C-terminal 10 aminoacyl residues (including the
hexa-His tag) are missing, as is the N-terminal methionine,
which was not seen in either the selenomethionine-substituted
TABLE I
Data and refinement statistics
Data Collection and MAD phasing statistics
Crystal Native Selenomethionine-substituted
SSRLa Beamline 7–1 1–5
Unit cell parameters (Å) a  49.4 a  50.1
b  67.8 b  67.6
c  115.0 c  116.1
Resolution limits (Å) 23.30–2.75 58.72–2.90
Outer shell (Å) 2.82–2.75 2.98–2.90
Wavelength (Å) 1.08 0.9226 0.97945 0.97988 1.06883
Observed reflections 42297 18,361 18,945 19,064 18,568
Unique reflections 5199 4502 4515 4523 4497
% Completeness (outer shell) 99.3 (99.0) 97.0 (100) 97.3 (100) 97.4 (100) 96.9 (93.5)
Mean I/I (outer shell) 7.9 (2.7) 4.2 (1.4) 4.0 (1.5) 6.4 (1.6) 5.1 (2.0)
Rsym (%)
b (outer shell) 7.2 (27.1) 6.7 (51.0) 6.8 (51.2) 5.3 (48.6) 5.1 (38.1)
MAD Figure of merit 0.688










Bond length deviation (Å) 0.013
Bond angle deviation (°) 1.5
Average B-factor (Å2) 81.61
a Stanford Synchrotron Radiation Laboratory.
b Rsym  I0  IavgI0.
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or native structures. The side chains of residues Glu-67, His-
71, Asn-73, and Lys-90 are disordered and have been modeled
as alanines.
The topological arrangement of secondary structural ele-
ments of MtaN begins with 1 (residues 2–4), followed by 1
(residues 5–12) and 2 (residues 16–24), which are connected
by a 3-residue turn and comprise the conserved and predicted
helix-turn-helix motif (20). Residues 25–31 form a loop that
connects 2 to strand 2 (residues 32–34), which is followed by
a type II -hairpin turn (residues 34–37) and strand 3 (resi-
dues 38–41). 3 is the center strand of a 3-stranded antipar-
allel -sheet. A dipeptide connects 3 to helix 3 (residues
43–58), which leads into a tight 3-residue turn that connects to
helix 4 (residues 62–70). A poorly structured loop (residues
71–75) connects the body (1 through 4) to a protruding
8-turn helix 5 (residues 76–104). Thus, the topology of the
MtaN monomer (1-1-2-2-3-3-4-5) is the same as that
of the N terminus of BmrR (27)(Fig. 2).
The monomer contains two functional domains: the N-termi-
nal DNA-contacting domain from 1 to 4 and the dimerization
domain consisting of helix 5 (Fig. 2). The DNA-binding do-
main is a member of the winged helix-turn-helix family of
proteins (39), consisting of a four-helix bundle and a three-
stranded antiparallel -sheet. The dimerization domain con-
sists of the 8-turn 5 helix that forms a two-helix antiparallel
coiled-coil with the other subunit. In BmrR 5 contains three
additional turns of helix that extend into the C-terminal do-
main. The strong conservation of this fold and that described
for BmrR (28% sequence identity) confirms the hypothesis that
this structure would be general for the MerR family.
DNA-binding Domain—The structure of MtaN is stabilized
by a hydrophobic core, which consists of side chains from 1
(Val-5, Val-8, Ala-9), 2 (Leu-19, Tyr-22, Asp-23), 3 (Arg-39,
Tyr-41), 3 (Leu-46, Leu-49, Ile-52, Phe-55, Ile-58), and 4
(Leu-62, Ile-65, Met-68, Leu-69) and turns between 1 and 2
(Val-14), 2 and 2 (Ile-25, Leu-27, Leu-28, Pro-30), and 3 and
4 (Phe-60). All but 2 of these 23 core residues (Ile-25 and
Pro-30) are well conserved across the MerR family (Fig. 3).
In addition to the hydrophobic component of the core, Asp-23
and Arg-39 form a buried salt bridge. This salt bridge but-
tresses the position of 3. In BmrR, this arginine (BmrR:Arg-
43) is turned away from the carboxylate group of the aspartate
(BmrR:Asp-26) to contact the DNA phosphate backbone. An
Arg is absolutely conserved at this position across the MerR
family and the Asp is either an Asp or Glu in all members but
MerR, where it is a Gln. Whereas a formal possibility is that
the Asp-23-Arg-39 salt bridge is in equilibrium with an un-
bridged conformer, such as that seen in BmrR, the high ionic
strength of the MtaN crystallization conditions (up to 5.0 M
LiCl) would be expected to disfavor the formation of this ob-
served salt bridge strongly. Given that Asp-23 and Arg-39 are
found to interact in this environment indicates that this is a
stable and physiologically relevant interaction. Thus this salt
bridge interaction, and its subsequent DNA-induced breaking,
is likely to be conserved in all MerR family members.
The reason for sequence conservation of MtaN and BmrR is
clear. Of the body, defined as 1 through 4, 26 of 69 MtaN and
BmrR residues are identical, and of those 26, 15 are found in
the core, and an additional 5 in turns. When conservative
substitutions are included, the number of homologous residues
rises to 36 and of those, 21 are found in the core. Thus, the
observed sequence conservation between the two proteins en-
sures the structural conservation of this hydrophobic core. The
same reasoning appears to apply across the whole family as
these residues are among the most conserved in the N-terminal
domain. Our analysis leads to the conclusion that DNA binding
by MerR proteins does not significantly alter the structure of
the hydrophobic core of the DNA-binding domains.
An overlay of C carbons of helices 1 through 4 of MtaN
onto the corresponding BmrR atoms results in a root mean
square (r.m.s.) deviation of 0.75 Å. That these four helices
overlay so well suggests that either this domain of MtaN has
taken the DNA-bound formation even in the absence of DNA,
or more likely there is no difference in relative positions of
these helices between the DNA-bound and free forms. How-
ever, residues Asp-47 and Ser-48 of BmrR 3 are displaced
FIG. 1. A stereo view of the overall
architecture of MtaN. Every tenth res-
idue is labeled.
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from their MtaN counterparts (Asp-43 and Ala-44) by their
connection to the -sheet, which takes a different conformation,
and by their direct interaction with the drug-binding domain of
BmrR, which is not present in MtaN.
Whereas the cores of MtaN and BmrR and the positions of
the body helices (1-4) are the same, a structural difference is
evident in the position of Wing 1 (2-turn-3). Specifically,
MtaN displays a type II -turn (Thr-34-Gly-37), whereas BmrR
does not contain this classic hairpin because of a single residue
insertion in this area, and is thus better described as a small
loop. In addition, MtaN Wing 1 makes crystal lattice contacts,
whereby Tyr-38 stacks against a symmetry-related Tyr-38. In
BmrR this residue (BmrR:Tyr-42) interacts with a base in the
minor groove. As a result, the C of Asp-35 (BmrR:Asp-39),
which is located at the crux of the -turn, moves 8.3 Å. Either
interaction (protein-protein or protein-DNA) might be enough
to displace the end of this -sheet and therefore, Wing 1. Such
wing flexibility is well documented in other winged-helix pro-
teins (40, 41). Regardless of its position in the current struc-
ture, Tyr-38 is likely to be involved in DNA binding by MtaN as
well. The more global shift in the rest of the wing is more likely
because of the absence of DNA and the different interactions of
conserved residue Arg-39, which forms a salt bridge to Asp-23
in MtaN and a DNA backbone contact in BmrR (BmrR:Arg-43).
Dimerization Domain—The MtaN dimer is stabilized pri-
marily by the formation of an antiparallel coiled-coil between
the amphipathic 5 helices. Coiled-coils are characterized by a
heptad repeat (abcdefg)n in which the a and d positions are
typically occupied by hydrophobic residues and form the inter-
face between the interacting helices (42, 43). In MtaN, the
hydrophobic core of the interface consists of the side chains of
residues Leu-80 (d1), Leu-87 (d2), Met-94 (d3), Ile-98 (a3),
Ile-101 (d4) and Leu-105 (a4), and the methylene carbons of
Lys-84 (a1) and Lys-91 (a2). In the antiparallel conformation
FIG. 2. A ribbon diagram of the
MtaN dimer. One subunit is colored
from blue at the N terminus to red at the
C terminus. The other is colored purple.
Secondary structural elements are la-
beled. The “body” domain includes 1, 1,
2, 2, 3, 3, and 4. The 5 helices form
the antiparallel coiled-coil.
FIG. 3. A sequence alignment of
MtaN and other MerR family mem-
bers. Conserved residues are color coded,
with decreasing conservation from red
shading (absolute) to white (more vari-
able). The secondary structure elements
of MtaN are shown above the alignment
and colored as in Fig. 2. Purple arrow-
heads denote residues with side chains
contributing to the core. Filled red circles
are MtaN residues involved in inter-
molecular salt-bridges. The a and d posi-
tions of the antiparallel coiled-coil are
indicated.
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found in MtaN, van der Waals contacts are from d1 to a4, a1
to d4, d2 to a3, a2 to d3, (where  indicates the dimer partner)
as well as the symmetry imposed interactions (Fig. 4). In ad-
dition to forming the antiparallel coiled-coil, the C-terminal
end of the 5 helix also interacts with the C terminus of 3.
Contacts are found between the side chain of Phe-54 and C of
Thr-104, and the alkyl side chains of Ile-58 and Ile-101. van
der Waals contacts between Glu-57 and Met-97 complete the
dimerization interface. Dimerization buries 738 Å2 of accessi-
ble surface area per monomer, which is average for many
oligomeric proteins (44).
Beyond the hydrophobic interactions, two a residues of
MtaN, Lys-84 and Lys-91 and their dyadic mates, form salt
bridges to Asp-102 and Asp-95, respectively, whereas the
corresponding BmrR residues do not. Interhelix ionic interac-
tions are common among both parallel and antiparallel coiled-
coils and serve to stabilize the dimer and prevent unwanted
heterodimerization (45, 46). Heterodimerization has not been
observed between MerR family members.
An antiparallel coiled-coil was first indicated in MerR (47–
49) and predicted to occur in all MerR family members (21),
which was confirmed by the structure determination of BmrR.
In both MtaN and BmrR, all d positions are occupied by hy-
drophobic residues, whereas their a positions vary significantly
(Fig. 4). Specifically, at MtaN a positions Lys-91, Ile-98, and
Leu-105, the respective BmrR residues are Leu, Glu, and Lys.
Where both proteins have hydrophilic a residues they are op-
positely charged (MtaN:Lys-84, BmrR:Glu-88). Overall, the
buried residues of the coiled-coil (80 through 105) are only
partially conserved across the family, even between MtaN and
TipAL, the most closely related MerR protein (13) (49% se-
quence identity). Only residues corresponding to Ile-101, which
is always hydrophobic, and Leu-80, Leu-87, Met-94, and Ile-98,
which are usually hydrophobic, are reasonably conserved (Fig.
3). Thus, the variation of buried residues serves to stabilize the
dimer and contributes to the prevention of heterodimerization.
Conformational Differences between Two MerR Family Mem-
bers—An overlay of the conserved four-helix core of one mono-
mer of MtaN onto the corresponding core of DNA-bound BmrR
revealed a significant shift in the relative positions of the
recognition helix (2) of the other subunit (Fig. 5). In MtaN
the center-to-center distance of these helices is 33.3 Å, close to
the 34 Å repeat distance of canonical B-form DNA and consist-
ent with their binding to consecutive major grooves. In the
transcription-activated conformation of BmrR these helices are
only 30.6 Å apart, which corresponds to their major-groove
binding to a shortened and undertwisted DNA double helix
(27). In addition to the distances, the relative positions of these
helices have changed with respect to each other. The resulting
position of the MtaN 2 is offset from the BmrR 2 by 7.5 Å,
largely because of the lateral twist of 15° of the dimer partner,
rather than a simple direct lengthening between the major
groove binding helices (Fig. 5, a and b).
The rotation between subunits is the result of two conforma-
tional changes that occur in the antiparallel coiled-coil. When
MtaN and BmrR helices 1 through 4 are overlaid, a shift in
the relative positions of their 5 helices is evident (Fig. 5, a and
FIG. 5. Conformational differences between MtaN and BmrR.
MtaN is in purple and the first 110 residues of BmrR are in gold. a,
superimposition of helices 1 through 4 (left monomers) reveals the
rotation of the 5 helix, altered positions of the -sheets and different
orientations of the 2 and 2 helices, which in MtaN are farther apart
and rotated counterclockwise. b, a view of the same overlay in a rotated
by 45°. This view highlights the different locations of the MtaN and
BmrR 2 helices, which are shifted 7.5 Å. c, superimposition of the 5
helices. The 5 C-terminal end of BmrR is revolved around the overlaid
5 helices as compared with MtaN, resulting in a large shift in the body
of the dimer partner and a smaller effect on the position of the monomer
body. d, the same overlay as c, but looking at the N terminus of 5 and
C terminus of 5. The remainder of the protein has been deleted for
clarity.
FIG. 4. A schematic diagram of the
antiparallel coiled-coil of MtaN. Inter-
subunit salt bridges between the a and e
positions are depicted by gray lines. Res-
idues at the a and d positions form the
hydrophobic core of the interacting
helices.
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b). In comparison to MtaN 5, the BmrR 5 has rotated 6.5°
up and away. The body of the dimer partner moves to match
this relocation to maintain the contacts between helices 5 and
3. This relatively small rotation is doubled by the same
rotation of the dimer partner, and further amplified by the
length of the coiled-coil. In addition to the rotation of the 5
helix, the relative conformations of the antiparallel coiled-coils
of MtaN and BmrR are different. When 5 of MtaN is overlaid
onto the 5 of BmrR (r.m.s. deviation is 0.63 Å for the C
carbons), the 5 helices do not overlay (Fig. 5, c and d). Rather,
the C-terminal end of the MtaN 5 helix has revolved 15° in
a counter-clockwise direction around the overlaid 5 helices.
The movement of the N terminus of 5 helix is smaller, but
changes the direction of the helical axis to match the revolution
that occurs at the C-terminal end. This revolution rotates the
body, i.e. the DNA-binding domain, of the dimer partner
around the axis of the coiled-coil and swings it toward the other
body domain, thereby accounting for the observed expansion of
the recognition helices of MtaN.
DNA-induced Conformational Changes—MtaN is a constitu-
tive activator, yet the dimer structures of MtaN and BmrR, the
latter of which is in its transcription-activated conformation,
are different. Perhaps the differences reflect dissimilar DNA-
binding modes in which MtaN twists its promoter DNA to a
lesser degree. Alternatively, the DNA binding site might play a
role in the induction of additional conformational changes in
MtaN so that it more closely resembles BmrR.
DNA-docking experiments reveal that the MtaN dimer is
unable to bind the BmrR-activated DNA (27) because its 2
major groove recognition helices are too far apart and in the
wrong orientation to fit into the major grooves (Fig. 5). MtaN is
also unable to bind canonical B-form DNA because the 2
helices are tilted incorrectly to fit directly into adjacent major
grooves and Wing 1 clashes with the DNA backbone. Thus at
the least, MtaN requires minor structural adjustment in the
twist of its 2 helices and more significant changes in the
position of its -sheet (Wing 1) to bind either DNA conforma-
tion (Figs. 5 and 6).
Given the results of our docking experiments a binding and
activation mechanism can be envisioned. In this proposal the
first step is MtaN binding to a B-like DNA conformation. This
would likely be concomitant with or followed by the breaking of
the Asp-23–Arg-39 salt bridge. The disruption would allow
Arg-39 to contact the DNA phosphate backbone, perhaps as
observed in the BmrR-bmr promoter complex (27) and remove
a key constraint that holds MtaN in a non-activating confor-
mation. Additional structural changes would be transmitted
through the coiled-coil and allow the MtaN conformation to
maximize its DNA contacts. This in turn could elicit DNA
conformational changes, which would result in an activated
conformation of the MtaN-mta promoter complex that would
more closely resemble that of the BmrR-bmr complex. The
structure of an MtaN-mta promoter complex should provide
more understanding of the DNA-binding and transcription ac-
tivation mechanisms of this MerR family member.
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